P.05.15: Use of Infliximab Biosimilar in our Center: Our Experience in Pharmacovigilance

Autor:	T. Zuppini, A. Variola, E. Capoferro, A. Geccherle, A. Massella, R. Tessari
Rok vydání:	2017
Předmět:	medicine.medical_specialty Hepatology business.industry Pharmacovigilance Gastroenterology medicine Center (algebra and category theory) Biosimilar Medical physics Pharmacology business Infliximab medicine.drug
Zdroj:	Digestive and Liver Disease. 49:e162
ISSN:	1590-8658
DOI:	10.1016/s1590-8658(17)30489-9
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8b43fbad0548f33e2d92b1bee9caa860 https://doi.org/10.1016/s1590-8658(17)30489-9 Zobrazit plný text záznamu Full Text from ScienceDirect